Financhill
Sell
47

GEHC Quote, Financials, Valuation and Earnings

Last price:
$83.63
Seasonality move :
19.47%
Day range:
$82.86 - $86.25
52-week range:
$71.31 - $94.55
Dividend yield:
0.15%
P/E ratio:
22.98x
P/S ratio:
1.96x
P/B ratio:
4.60x
Volume:
4.1M
Avg. volume:
3.1M
1-year change:
9.83%
Market cap:
$38.2B
Revenue:
$19.6B
EPS (TTM):
$3.64

Analysts' Opinion

  • Consensus Rating
    GE HealthCare Technologies has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 5 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $96.76, GE HealthCare Technologies has an estimated upside of 15.65% from its current price of $83.66.
  • Price Target Downside
    According to analysts, the lowest downside price target is $74.00 representing 11.55% downside risk from its current price of $83.66.

Fair Value

  • According to the consensus of 17 analysts, GE HealthCare Technologies has 15.65% upside to fair value with a price target of $96.76 per share.

GEHC vs. S&P 500

  • Over the past 5 trading days, GE HealthCare Technologies has underperformed the S&P 500 by -1.68% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • GE HealthCare Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • GE HealthCare Technologies has grown year-over-year revenues for 2 quarters straight. In the most recent quarter GE HealthCare Technologies reported revenues of $4.9B.

Earnings Growth

  • GE HealthCare Technologies has grown year-over-year earnings for 3 quarters straight. In the most recent quarter GE HealthCare Technologies reported earnings per share of $1.02.
Enterprise value:
45.2B
EV / Invested capital:
--
Price / LTM sales:
1.96x
EV / EBIT:
15.65x
EV / Revenue:
2.31x
PEG ratio (5yr expected):
4.17x
EV / Free cash flow:
26.65x
Price / Operating cash flow:
22.64x
Enterprise value / EBITDA:
13.02x
Gross Profit (TTM):
$8.1B
Return On Assets:
5.15%
Net Income Margin (TTM):
8.57%
Return On Equity:
21.64%
Return On Invested Capital:
9.61%
Operating Margin:
13.9%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $18B $19.3B $19.6B $4.8B $4.9B
Gross Profit $7.1B $7.7B $8.1B $1.9B $2B
Operating Income $2.5B $2.5B $2.5B $617M $676M
EBITDA $3.2B $3.6B $3.5B $927M $931M
Diluted EPS $4.23 $3.45 $3.64 $0.82 $1.02
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets -- -- $7.3B $9.5B $10.6B
Total Assets -- -- $26.1B $32.4B $33.9B
Current Liabilities -- -- $6.6B $7.6B $8.7B
Total Liabilities -- -- $9.2B $25.1B $25.3B
Total Equity -- -- $16.9B $7.3B $8.5B
Total Debt -- -- $43M $10.3B $10.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -- $2.1B $2.1B $650M $738M
Cash From Investing -- -$565M -$762M -$120M -$137M
Cash From Financing -- $385M -$196M -$24M $914M
Free Cash Flow -- $1.7B $1.7B $570M $648M
GEHC
Sector
Market Cap
$38.2B
$46M
Price % of 52-Week High
88.48%
46.82%
Dividend Yield
0.15%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
9.83%
-34.78%
Beta (5-Year)
--
0.748
Dividend yield:
0.15%
Annualized payout:
$0.00
Payout ratio:
3.22%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $83.72
200-day SMA
Buy
Level $83.49
Bollinger Bands (100)
Sell
Level 81.44 - 89.62
Chaikin Money Flow
Buy
Level 123.4M
20-day SMA
Buy
Level $80.79
Relative Strength Index (RSI14)
Buy
Level 55.97
ADX Line
Buy
Level 25.72
Williams %R
Neutral
Level -37.5258
50-day SMA
Buy
Level $82.51
MACD (12, 26)
Buy
Level 0.66
25-day Aroon Oscillator
Buy
Level 44
On Balance Volume
Sell
Level -9.8M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.8108)
Sell
CA Score (Annual)
Level (-0.8068)
Buy
Beneish M-Score (Annual)
Level (-2.4831)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.7425)
Buy
Piotroski F Score (Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

Stock Forecast FAQ

In the current month, GEHC has received 11 Buy ratings 5 Hold ratings, and 1 Sell ratings. The GEHC average analyst price target in the past 3 months is $96.76.

  • Where Will GE HealthCare Technologies Stock Be In 1 Year?

    According to analysts, the consensus estimate is that GE HealthCare Technologies share price will rise to $96.76 per share over the next 12 months.

  • What Do Analysts Say About GE HealthCare Technologies?

    Analysts are divided on their view about GE HealthCare Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GE HealthCare Technologies is a Sell and believe this share price will drop from its current level to $74.00.

  • What Is GE HealthCare Technologies's Price Target?

    The price target for GE HealthCare Technologies over the next 1-year time period is forecast to be $96.76 according to 17 Wall Street analysts, 11 of them rate the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is GEHC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for GE HealthCare Technologies is a Buy. 11 of 17 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of GEHC?

    You can purchase shares of GE HealthCare Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GE HealthCare Technologies shares.

  • What Is The GE HealthCare Technologies Share Price Today?

    GE HealthCare Technologies was last trading at $83.63 per share. This represents the most recent stock quote for GE HealthCare Technologies. Yesterday, GE HealthCare Technologies closed at $83.66 per share.

  • How To Buy GE HealthCare Technologies Stock Online?

    In order to purchase GE HealthCare Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How To Create A Covered Call Trade Strategy
How To Create A Covered Call Trade Strategy

After you have done some homework on a stock and…

How To Use Covered Calls To Generate Income
How To Use Covered Calls To Generate Income

The Covered Call Defined A covered call is the sale…

Is Target a Dividend King?
Is Target a Dividend King?

Popular retail giant Target Corporation (NYSE:TGT) has been in a…

Stock Ideas

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
43
QMCO alert for Jan 16

Quantum [QMCO] is down 0.84% over the past day.

Sell
34
IONQ alert for Jan 16

IonQ [IONQ] is down 2.49% over the past day.

Sell
47
FTAI alert for Jan 16

FTAI Aviation [FTAI] is up 4.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock